Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®
- PMID: 22305839
- PMCID: PMC3273846
- DOI: 10.1016/j.ahj.2011.08.024
Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®
Abstract
Background: There are many factors hypothesized as contributing to overuse of percutaneous coronary intervention (PCI) in the United States, including financial ties between physicians and hospitals, but empirical data are lacking. We examined PCI indications in not-for-profit (NFP), major teaching, for-profit (FP), and physician-owned specialty hospitals.
Methods: A retrospective cohort study of 1,113,554 patients who underwent PCI in 694 hospitals (NFP 471, teaching 131, FP 79, specialty 13) participating in the CathPCI Registry® between January 1, 2004, and December 31, 2007. Percutaneous coronary intervention indications derived from American College of Cardiology Guidelines were classified as survival benefit (patients with primary reperfusion for ST-elevation myocardial infarction), potential quality of life benefit (patients with non-ST-elevation myocardial infarction, acute coronary syndrome (ACS), positive stress test, or chest pain), or unclear indications (patients receiving PCI without an obvious potential survival or quality of life benefit).
Results: The percentage of PCI performed for unclear indications was somewhat higher for specialty hospitals (5.1% of all procedures) as compared with other hospital categories (FP 4.7%, NFP 4.2%, major teaching 4.5%; P < .001). Overall, 17% of hospitals had ≥20% of their total PCI procedures performed for unclear indications, but the proportion of FP, NFP, major teaching, and specialty hospitals reaching this threshold was not statistically different (20%, 16%, 17%, and 15%, respectively; P = .84).
Conclusions: A small proportion of PCI procedures were performed in patients with unclear indications, but there was wide variation across hospitals. On average, specialty hospitals performed more PCIs for unclear indications. Efforts to reduce variability should be pursued.
Copyright © 2012 Mosby, Inc. All rights reserved.
Figures
References
-
- Holmes JS, Kozak LJ, Owings MF. Use and in-hospital mortality associated with two cardiac procedures, by sex and age: national trends, 1990-2004. Health Aff (Millwood) 2007 Jan-Feb;26(1):169–177. - PubMed
-
- Groeneveld PW, Matta MA, Greenhut AP, Yang F. The costs of drug-eluting coronary stents among Medicare beneficiaries. American Heart Journal. 2008 Jun;155(6):1097–1105. - PubMed
-
- Kozak LJ, Lees KA, DeFrances CJ. National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics. Series 13: Data from the National Health Survey. 2006 May;(160):1–206. - PubMed
-
- Writing Group M. Lloyd-Jones D, Adams R, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 January 27;119(3):480–486. 2009. - PubMed
-
- Klein B, Zahn R, Heer T, et al. [Temporal trends in the use of drug-eluting stents in German clinical practice] Herz. 2008 Sep;33(6):450–454. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
